A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands

Journal of Computational Chemistry - Tập 25 Số 11 - Trang 1385-1399 - 2004
Da‐Woon Jung1, Jie Floyd1, Tamara Gund1
1Department of Chemistry, and Environmental Science, New Jersey Institute of Technology, Newark, New Jersey 17102-1982

Tóm tắt

Abstract

The Comparative Molecular Field Analysis (CoMFA) was developed to investigate a three‐dimensional quantitative structure activity relationship (3D‐QSAR) model of ligands for the sigma 1 receptor. The starting geometry of sigma‐1 receptor ligands was obtained from the Tripos force field minimizations and conformations were decided from DISCOtech using the SYBYL 6.8. program. The structures of 48 molecules were fully optimized at the ab initio HF/3‐21G* and semiempirical AM1 calculations using GAUSSIAN 98. The electrostatic charges were calculated using several methods such as semiempirical AM1, density functional B3LYP/3‐21G*, and ab initio HF/3‐21G*, MP2/3‐21G* calculations within GAUSSIAN 98. Using the optimized geometries, the CoMFA results derived from the HF/3‐21G method were better than those from AM1. The best CoMFA was obtained from HF/3‐21G* optimized geometry and charges (R2 = 0.977). Using the optimized geometries, the CoMFA results derived from the HF/3‐21G methods were better than those from AM1 calculations. The training set of 43 molecules gave higher R2 (0.989–0.977) from HF/3‐21G* optimized geometries than R2 (0.966–0.911) values from AM1 optimized geometries. The test set of five molecules also suggested that HF/3‐21G* optimized geometries produced good CoMFA models to predict bioactivity of sigma 1 receptor ligands but AM1 optimized geometries failed to predict reasonable bioactivity of sigma 1 receptor ligands using different calculations for atomic charges. © 2004 Wiley Periodicals, Inc. J Comput Chem 25: 1385–1399, 2004

Từ khóa


Tài liệu tham khảo

10.1016/S0065-7743(08)60871-4

Walker J. M., 1990, Pharmacol Rev, 42, 355

10.1016/S0960-894X(01)00788-0

10.1021/jm020889p

10.1021/jm010501a

10.1016/S0014-2999(01)01229-8

10.1016/S0014-2999(96)00602-4

10.1016/0014-2999(94)90517-7

10.1016/0024-3205(93)90588-T

10.1111/j.1527-3458.1996.tb00299.x

10.1016/0014-2999(94)90424-3

10.1021/jm980556l

10.1021/ja00226a005

10.1021/jm980369n

Gaillard P., 1998, J Med Chem, 39, 126, 10.1021/jm950410b

10.1021/jm980026p

10.1021/jm980631s

Shim J. Y., 1999, J Med Chem, 41, 4521, 10.1021/jm980305c

10.1021/jm9800292

10.1016/S0223-5234(98)80021-4

Bursi R., 1999, J Comput Aided Mol Design, 13, 221, 10.1023/A:1008010016362

10.1023/A:1008002602653

10.1021/ci0001278

10.1021/jm970740r

10.1021/jm00039a008

10.1016/S0014-2999(97)01248-X

10.1016/S0028-3908(96)00161-X

10.1016/S0969-8051(97)00097-8

10.1021/jm960720

2001, SYBYL 6.8

10.1007/BF00141577

10.1021/jm980409n

Gund T. M., J Mol Graphics Model

Gund T. M., 1991, J Math Chem, 8, 309, 10.1007/BF01166945

Manallack D.T., 1988, Mol. Pharmacol, 34, 863

10.1016/0014-2999(87)90524-3

Frisch M. J., 2001, Gaussian 98

Kenny P. W., 1994, J Chem Soc Perkin Trans 2, 2, 199, 10.1039/p29940000199

10.1007/BF00124364

Cark M., 1993, Quantum Struct Act Relat, 12, 137, 10.1002/qsar.19930120205